Analyze CompuMed (CMPD) and the competition

CompuMed (OTCMKTS: CMPDGet a rating) is one of 144 publicly traded companies in the Data Processing and Preparation industry, but how does it stack up against its peers? We will compare CompuMed to similar companies based on its dividend strength, valuation, analyst recommendations, institutional ownership, risk, earnings and profitability.

Insider and Institutional Ownership

50.9% of the shares of all “Data processing and preparation” companies are held by institutional investors. 22.0% of CompuMed’s shares are held by insiders. By comparison, 19.1% of the shares of all “data processing and preparation” companies are held by insiders. Strong institutional ownership indicates that large fund managers, hedge funds, and endowments believe a stock is poised for long-term growth.


This table compares the net margins, return on equity and return on assets of CompuMed and its peers.

Net margins Return on equity return on assets
CompuMed 13.60% 27.66% 17.49%
CompuMed competitors -37.88% -1,406.71% -6.41%

Analyst Notes

This is a breakdown of recent ratings and recommendations for CompuMed and its peers, as reported by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
CompuMed 0 0 0 0 N / A
CompuMed competitors 336 2353 4554 58 2.59

As a group, the “Data processing and preparation” companies have an upside potential of 81.09%. Given that CompuMed’s peers have higher upside potential, analysts clearly believe that CompuMed has less favorable growth aspects than its peers.

Volatility and risk

CompuMed has a beta of 1.44, suggesting its stock price is 44% more volatile than the S&P 500. Comparatively, CompuMed’s peers have a beta of 1.38, suggesting their average stock price is 38% more volatile than the S&P 500.

Valuation and benefits

This table compares revenue, earnings per share (EPS), and valuation of CompuMed and its peers.

Gross revenue Net revenue Price/earnings ratio
CompuMed $6.32 million $1.07 million 267.63
CompuMed competitors $868.32 million -$1.99 million -27.04

CompuMed’s peers have higher earnings, but lower earnings than CompuMed’s. CompuMed trades at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.


CompuMed beats its peers on 7 of the 10 factors compared.

CompuMed Company Profile (Get a rating)

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services to patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to US Board-certified specialists through cloud-based technology and medical devices integrated into medical facilities around the world. The company provides enterprise telemedicine solutions, such as a specialist network, cloud-based telemedicine technology, telemedicine-enabled medical devices, 24/7 call center customer support. 7, professional and training services; a suite of telecardiology services and diagnostic test interpretations for pediatric and adult patients, including electrocardiogram (ECG) machines, echocardiogram, ECG, vascular, holter, nuclear and video consultations; and playback, transcription, report, storage and video consultations in the fields of Vscan, x-rays, ultrasound, mammography, computed tomography, magnetic resonance imaging and radiologist video consultations. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis and treatment monitoring. Additionally, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its certified specialists; and Vscan, a pocket-sized, portable viewing tool that houses ultrasound technology, which builds clinical confidence for physicians and aids in rapid diagnosis. It serves organ procurement organizations, rural health care, and correctional health care industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

Get news and reviews for CompuMed Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for CompuMed and related companies with’s FREE daily email newsletter.

Comments are closed.